Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. brought in $4.7M of revenue over the twelve months to June 30, 2026, down 12.2% from a year earlier. It posted a net loss of $11.1M. In fiscal 2025 capital spending exceeded operating cash flow by $4.7M. At June 30, 2026 it held $4.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Watch RKDA in 60 secondsWhat Arcadia Biosciences, Inc. does
Arcadia Biosciences, Inc. is registered with the SEC under industry code SIC 1311 (Crude Petroleum & Natural Gas). Its shares trade on NASDAQ under the ticker RKDA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $4.9M | -$2.3M | -$1.71 | -$4.7M |
| 2024 | $5M | -$7M | -$5.17 | -$9.6M |
| 2023 | $4.5M | -$14M | -$11.29 | -$15.3M |
| 2022 | $7.4M | -$15.4M | -$25.65 | -$14M |
| 2021 | $6.8M | -$14.7M | -$27.56 | -$26.9M |
| 2020 | $8M | -$4.7M | -$18.77 | -$32.6M |
Full financial statements: income, balance sheet and cash flow
Where RKDA ranks in Energy
Latest SEC filings
What Arcadia Biosciences, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 15, 2026
- September 4, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 0.8% to $1.4M versus the same quarter last year; diluted EPS -$2.09 versus -$3.26.
- August 13, 2026
- August 10, 2026
- August 10, 2026Proxy statement DEF 14A
- August 10, 2026
- July 31, 2026Preliminary proxy statement PRE 14A
- July 9, 2026
Insider trades
What the people running Arcadia Biosciences, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns RKDA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Armistice Capital, LLC13G, passive with 1 related filers | 9.99% | August 14, 2026 |
Largest institutional holders
Insiders
Questions about RKDA
What does Arcadia Biosciences, Inc. do?
Arcadia Biosciences, Inc. is registered with the SEC under industry code SIC 1311 (Crude Petroleum & Natural Gas). Its shares trade on NASDAQ under the ticker RKDA.
Is Arcadia Biosciences, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $11.1M on revenue of $4.7M.
How much revenue does Arcadia Biosciences, Inc. make?
Over the twelve months to June 30, 2026 Arcadia Biosciences, Inc. reported revenue of $4.7M. That is 12.2% less than a year earlier.
When did Arcadia Biosciences, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the executive or director change from September 15, 2026.
Similar companies
Compare RKDA with
Follow RKDA
Get an email when Arcadia Biosciences, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow RKDA: get an email when it filesWhere the numbers come from
Financial figures are the values Arcadia Biosciences, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.